Effective Date:10/11/2007 |
Title:Torisel (Temsirolimus)
|
Revision Date:07/01/2017
|
Document:BI214:00
|
CPT Code(s):See Chart
|
Public Statement
|
Effective Date:
a)
This policy
will apply to all services performed on or after the above revision date which
will become the new effective date.
b)
For all
services referred to in this policy that were performed before the revision
date, contact customer service for the rules that would apply.
1)
Torisel (temsirolimus)
is an injectable medication which is used in the treatment of advanced kidney
cancer, certain soft tissue sarcoma, and endometrial carcinoma.
2)
Torisel is
covered under the medical benefit as a specialty drug for the conditions listed
above.
QualChoice considers treatment of other cancers with Torisel to be experimental
and investigational and is not covered.
|
Medical Statement
|
Torisel is considered
medically necessary in the treatment of the following diagnoses:
1)
Advanced
renal cell carcinoma OR
2)
Soft Tissue
Sarcoma – PEComa/Recurrent Angiomyolipoma/Lymphangioleiomyomatosis OR
3)
Endometrial
Carcinoma
Codes
Used In This BI:
J9330 Inj, Temsirolimus, 1mg
|
Limits
|
Intentially left empty
|
Reference
|
1)
Torisel Prescribing
Information. Pfizer Inc. Philadelphia, PA. July 2016.
2)
Clinical Pharmacology.
Accessed online 5/22/17
3)
NCCN Drugs & Biologics
Compendium. Accessed online 5/22/2017
Addendum:
1.
Effective 07/01/2017:
Updated to include covered diagnoses of soft tissue sarcoma – PEComa/Recurrent
angiomyolipoma/lymphangioleiomyomatosis and endometrial carcinoma.
|
Application to Products
|
This
policy applies to all health plans and products administered by QualChoice, both
those insured by QualChoice and those that are self-funded by the sponsoring
employer, unless there is indication in this policy otherwise or a stated
exclusion in your medical plan booklet. Consult the individual plan sponsor
Summary Plan Description (SPD) for self-insured plans or the specific Evidence
of Coverage (EOC) or Certificate of Coverage (COC) for those plans or products
insured by QualChoice. In the event of a discrepancy between this policy and a
self-insured customer’s SPD or the specific QualChoice EOC or COC, the SPD, EOC,
or COC, as applicable, will prevail. State and federal mandates will be
followed as they apply.
The Federal
Employees Health Benefit Program (FEHBP) has different coverage. Please see
refer to your policy brochure.
|
Changes: QualChoice reserves the right to alter, amend, change or supplement benefit interpretations as needed.
|